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of Acute Aortic Dissection From the
Aortic Community*
John A. Elefteriades, MD, Bulat A. Ziganshin, MDI n this issue of the Journal, Pape et al. (1) from theInternational Registry of Acute Aortic Dissection(IRAD) group analyzed trends in the presenta-
tion, diagnosis, and outcomes of aortic dissection
over the 17-year history of IRAD. They found that
the following occurred between 1999 and 2013:
 Clinical presentation of acute aortic dissection did
not change.
 Use of computed tomography (CT) as the diag-
nostic modality increased.
 The role of chest x-rays in diagnosis of acute
dissection diminished.
 Surgical results for type A and type B aortic
dissection improved.
 Endovascular therapies were applied increasingly
for type B dissection.
 Beta-blockers, angiotensin receptor blockers (ARBs),
diuretics, and statins were prescribed more fre-
quently at hospital discharge following acute aortic
dissection.
 Hospital mortality improved for type A aortic
dissection but not for type B.SEE PAGE 350The conception and implementation of the IRAD
database and project in 1996, under the direction of*Editorials published in the Journal of the American College of Cardiology
reﬂect the views of the authors and do not necessarily represent the
views of JACC or the American College of Cardiology.
From the Aortic Institute at Yale-New Haven Hospital, Yale University
School of Medicine, New Haven, Connecticut. Dr. Elefteriades is a
shareholder of CoolSpine; and is a member of the Data Safety Monitoring
Board for Jarvik Heart; neither of which is relevant to this publication. Dr.
Ziganshin has reported that he has no relationships relevant to the con-
tents of this paper to disclose.Drs. Kim Eagle, Christophe Nienaber, and Eric Issel-
bacher, represented a brilliant brainchild that has
contributed immensely to the advancement of care
in management of aortic diseases. We identiﬁed 61
major scientiﬁc papers written by the IRAD group
between 2000 and 2014 (Online Table 1). These pub-
lications have permitted us to “feel the elephant” that
is aortic dissection. We consider the publications lis-
ted in Table 1 to be among the 10 most important
contributions by IRAD.
In terms of the current paper on “trends” (1) over
the lifetime of IRAD, we would like to make several
observations.
The investigators pointed out that presenting signs
and symptoms of aortic dissection did not change,
but we would not have expected them to because that
would require natural alterations in the biology of the
disease—a process that could be expected to take
millennia rather than over 2 decades.
The investigators seemed pleased that more beta-
blockers, diuretics, and ARBs—and fewer vasodila-
tors—are being used in the discharge regimens of
patients treated for acute aortic dissection. However,
the recent study by Lacro et al. (2) fell short of ex-
pectations with regard to the beneﬁt of ARBs in
Marfan’s syndrome. Our review of the impact of beta-
blockers on patients with Marfan’s syndrome showed
equivocal and unconvincing beneﬁt (3,4). Therefore,
we are not certain that the changes in medication
patterns noted in the IRAD paper are of clear-cut
beneﬁt. The investigators likely had in mind the
presumed beneﬁt of anti-impulse therapy post-
dissection, which we support.
As surgeons, we are very pleased by the decreased
mortality for operations on acute type A and type B
aortic dissections. It seems that advances in diagnosis
and in surgical techniques are bearing fruit. Grafts
FIGURE 1 IRAD Analysis Is Limited by the “Referral Hospital” Rather Than
“Community Population” Perspective
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The International Registry of Acute Aortic Dissection (IRAD) demonstration of the
“paradox” that many aortic dissections occur at small aortic sizes exempliﬁes this issue.
(A)We conﬁrmed that aortic size follows a modiﬁed bell curve distribution. The population
at risk increases dramatically moving leftward from the right “tail” of the bell curve. The
corollary of this observation is that, at small aortic sizes, a huge population is at risk;
therefore, although dissections do occur, the relative risk is very low compared with the
huge “at-risk” population. Modiﬁed with permission from Elefteriades and Farkas (17).
(B) The relative risk is >6,000-fold higher for large aortas than for small ones. This
vindicates traditional intervention criteria. Reprinted with permission from Paruchuri et al. (6).
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360have become impervious, coagulation is managed
better intra- and post-operatively, brain protection has
improved, and the importance of an “open” distal
anastomosis has been recognized and disseminated.
We are disappointed that overall in-hospital mortality
of type B aortic dissection did not improve and ac-
tually increased in the last 2 periods and also failed to
show a positive overall impact of endovascular therapies.
We are not surprised that the chest x-ray has
assumed lesser importance because undoubtedly
many dissections can now be diagnosed by CT that
would not even be discernible if a chest x-ray were
done.The investigators indicate that one of their goals is
“to improve the care of these patients worldwide,”
and their hope is that information from their registry
“be utilized to inﬂuence algorithms for diagnosis and
treatment.” Undoubtedly, many of the IRAD in-
vestigations and publications have served this goal.
However, we are hard-pressed to identify speciﬁc
beneﬁcial changes in practice that could be imple-
mented on the basis of this particular paper on trends
in aortic disease over the course of IRAD.
As wonderful as IRAD has been, the IRAD database
method has limitations, which the investigators
discuss frankly in this paper.
IRAD data are collected retrospectively, there is no
core laboratory for image review, and the tertiary
referral nature of the IRAD centers impairs its ability
to be “representative of all patients with acute aortic
dissection.”
IRAD information comes from a referral hospital
basis rather than a community population basis, with
consequent inherent potential for misleading statis-
tics (5). One example is the “dissection paradox,”
about which we have recently written (6). IRAD
identiﬁed that many dissections occur at aortic di-
ameters below accepted criteria for intervention (6).
However, in mathematical terms, IRAD could see only
the “numerator” of the dissection fraction and does
not know the denominator at risk at each different
size range (Figure 1A). Wisely, the IRAD group did not
recommend any change in intervention criteria. We
recently applied mathematical analysis to the IRAD
data, with input of additional information on the
percentage of the normal population with aortas in all
size ranges (6). In other words, we approached the
“denominator” at risk in the dissection fraction, as
well as the dissected “numerator.” We conﬁrmed
that, although dissections do occur at small sizes,
patients with large aortas are at a 6,000-fold higher
risk of experiencing aortic dissection (Figure 1B).
Thus, the dissection paradox is resolved by extra
IRAD population base information, and traditional
criteria for intervention are vindicated. Analysis of
this paradox issue illustrates precisely the “hospital
versus population” issues to which Nienaber, one of
the IRAD founders, has insightfully called attention
(5). It can be helpful to have population informa-
tion in addition to knowledge of dissected patients
only (5).
It is difﬁcult or impossible to “drill down” to
identify underlying causative factors for IRAD obser-
vations from data that are limited to the 290-item
data form. For example, IRAD often does not know
causes of death. Speciﬁcs of operative management
also may be opaque to IRAD. Thus, single-center
TABLE 1 10 Most Important Contributions by IRAD (Among Many Others)
First Author, Year of
Publication (Ref. #) Journal Major Findings
Hagan et al., 2000 (7) Journal of the American Medical Association Described manifestations of acute aortic dissection.
Mehta et al., 2002 (8) Circulation Developed a simple risk prediction tool.
Moore et al., 2002 (9) American Journal of Cardiology Demonstrated high sensitivity for all 4 imaging techniques:
CT, MRI, TEE, and angiography.
Mehta et al., 2002 (10) Circulation Described circadian and seasonal variations in incidence.
Januzzi et al., 2004 (11) Journal of the American College of Cardiology Identiﬁed the importance of Marfan’s syndrome, bicuspid
aortic valve, and aortic enlargement in young patients.
Tsai et al., 2007 (12) New England Journal of Medicine Established partial thrombosis as a predictor of poor
post-discharge prognosis.
Pape et al., 2007 (13) Circulation Demonstrated that many dissections occur before accepted
size criteria are achieved.
Suzuki et al., 2009 (14) Circulation Demonstrated the high sensitivity of D-dimer elevation
in detecting aortic dissection.
Suzuki et al., 2012 (15) American Journal of Cardiology Demonstrated the beneﬁt of beta-blockers and lack of
beneﬁt of ACE inhibitors.
Dean et al., 2014 (16) American Journal of Medicine Called attention to cocaine as an important etiological factor
for acute aortic dissection in the present era.
ACE ¼ angiotensin-converting enzyme; CT ¼ computed tomography; IRAD ¼ International Registry of Acute Aortic Dissection; MRI ¼ magnetic resonance imaging;
TEE ¼ transesophageal echocardiography.
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361studies, in which data can be drilled as deeply
as needed, still have an important role in the
IRAD era.
The diagnosis of Marfan’s syndrome is not always
easy and may not be uniformly applied among all
28 centers in IRAD, and this has implications for
conclusions based on the presence or absence of
Marfan’s syndrome.
Long-term follow-up data are another issue with
IRAD. We have the impression that such long-term
data are not entirely and easily accessible via the
IRAD system, which is focused on the initial hos-
pital admission. If so, then this is another reason
why single-institution studies remain relevant; late
complications or progression, late reoperations,
and late death are more easily discovered and
documented.
Some observers might take issue with the strong
industry support of IRAD’s efforts. However, this
funding has permitted the advancements that IRADhas made throughout the years and the sustenance of
this collaborative scientiﬁc network.
We believe that we speak for the general “aortic
community” in recognizing and applauding the
extraordinary contributions to the understanding of
aortic disease and the advancement of its care made
by the IRAD program. This brilliant IRAD mechanism,
along with the insight, wisdom, and diligent work of
its members and staff, has shed tremendous light on
the “silent killer” of aortic disease and the “great
masquerader” represented by aortic dissection. We
are indebted to IRAD for this extraordinary body of
work, culminating in the present 17-year review paper
in this issue of the Journal.
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